D. E. Shaw & Co., Inc. - AXSOME THERAPEUTICS INC ownership

AXSOME THERAPEUTICS INC's ticker is AXSM and the CUSIP is 05464T104. A total of 184 filers reported holding AXSOME THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.99 and the average weighting 0.4%.

Quarter-by-quarter ownership
D. E. Shaw & Co., Inc. ownership history of AXSOME THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$2,418,194
-2.7%
34,6000.0%0.00%0.0%
Q2 2023$2,486,356
+31.7%
34,600
+13.1%
0.00%
+50.0%
Q1 2023$1,887,408
+144.7%
30,600
+206.0%
0.00%
+100.0%
Q4 2022$771,300
+197.8%
10,000
+47.9%
0.00%
Q2 2022$259,000
-96.0%
6,762
-95.6%
0.00%
-100.0%
Q1 2022$6,432,000
+89.2%
155,392
+72.7%
0.01%
+100.0%
Q4 2021$3,400,000
+134.8%
90,000
+104.8%
0.00%
+200.0%
Q3 2021$1,448,000
-70.9%
43,939
-40.5%
0.00%
-75.0%
Q2 2021$4,982,000
+4.7%
73,849
-12.1%
0.00%
-20.0%
Q1 2021$4,757,000
-73.2%
84,018
-61.5%
0.01%
-68.8%
Q4 2020$17,759,000
-11.6%
217,982
-22.7%
0.02%
-23.8%
Q3 2020$20,096,000
-20.3%
282,042
-8.0%
0.02%
-30.0%
Q2 2020$25,219,000
+2.2%
306,503
-26.9%
0.03%
-23.1%
Q1 2020$24,679,000
+155.4%
419,495
+348.8%
0.04%
+254.5%
Q4 2019$9,661,000
+297.9%
93,463
-22.1%
0.01%
+266.7%
Q3 2019$2,428,000
+171.3%
119,951
+245.1%
0.00%
+200.0%
Q2 2019$895,00034,7560.00%
Other shareholders
AXSOME THERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
ALETHEA CAPITAL MANAGEMENT, LLC 1,009,799$82,268,00041.24%
Fairmount Funds Management LLC 220,098$17,931,0006.41%
WMS Partners, LLC 250,000$20,368,0003.51%
IRIDIAN ASSET MANAGEMENT LLC/CT 2,064,158$168,167,0003.06%
MORGAN JESS S & CO INC 44,468$3,623,0002.88%
RTW INVESTMENTS, LP 1,672,416$136,252,0002.29%
RA Capital Management 1,655,447$134,869,0001.88%
Nicholas Investment Partners, LP 207,452$16,901,0001.30%
Affinity Asset Advisors, LLC 25,000$2,037,0001.08%
Parkman Healthcare Partners LLC 30,758$2,506,0000.64%
View complete list of AXSOME THERAPEUTICS INC shareholders